Canopy Growth CGC
NASDAQ CGC
$1.05 +0.01 (+1.44%)
As of: Aug 20, 2026 · 3:59 PM EDT

Canopy Growth (CGC) Change in Accured Expenses (2019 - 2026)

Canopy Growth (CGC) posted Change in Accured Expenses of -$1.6 million for Q4 2025, down 141.74% sequentially from $3.7 million in Q2 2025, and down 143.64% YoY from $3.6 million in Q4 2024.

Canopy Growth (CGC) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Canopy Growth has reported Change in Accured Expenses for 7 years, with the latest figure at -$1.6 million in Q4 2025.

  • Quarterly Change in Accured Expenses fell 143.64% year-over-year to -$1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.0 million (up 6.19% YoY) and the FY2026 annual result came in at -$3.2 million, up 70.58% from the prior year.
  • Change in Accured Expenses slipped to -$1.6 million in Q4 2025 per CGC's latest filing, from $3.7 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $10.7 million in Q3 2021 and troughed at -$27.4 million in Q4 2021.
  • A 5-year average of -$3.2 million and a median of -$2.9 million in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses soared 983.78% in 2021, then sank 453.49% in 2022.
  • Over 5 years, Change in Accured Expenses stood at -$27.4 million in 2021, then jumped by 84.85% to -$4.2 million in 2022, then soared by 346.37% to $10.2 million in 2023, then sank by 65.02% to $3.6 million in 2024, then slumped by 143.64% to -$1.6 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.6 million, $3.7 million, and $3.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 82.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Canopy Growth 445.49 Mn 198.48 Mn 16.08 Mn -1.75 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.75 Mn
Jun 30, 2026 -1.75 Mn
Dec 31, 2025 -1.56 Mn
Dec 31, 2025 -1.56 Mn
Jun 30, 2025 3.74 Mn
Jun 30, 2025 3.74 Mn
Dec 31, 2024 3.58 Mn
Dec 31, 2024 3.58 Mn
Sep 30, 2024 -11.79 Mn
Sep 30, 2024 -11.79 Mn
Jun 30, 2024 -4.32 Mn
Jun 30, 2024 -4.32 Mn
Mar 31, 2024 6.10 Mn
Mar 31, 2024 6.10 Mn
Dec 31, 2023 10.23 Mn
Dec 31, 2023 10.23 Mn
Sep 30, 2023 3.71 Mn
Sep 30, 2023 3.71 Mn
Jun 30, 2023 -13.41 Mn
Jun 30, 2023 -13.41 Mn